Study Stopped
Slow recruitment, advances in technology
Contribution of Narrow Band Imaging (NBI) for the Characterization of Scalloped Polyps (NBI POLYPES COLIQUES)
1 other identifier
interventional
314
1 country
2
Brief Summary
This prospective bicentric trial aims to evaluate the diagnostic performance of the characterization of scalloped polyps less than 20 millimeter in NBI (Narrow Band Imaging) in patients with screening colonoscopy. The NBI is a so-called "virtual" electronic staining technique available on conventional OLYMPUS endoscopes without additional intervention. The colonoscopy procedure for each patient will not be different from a conventional colonoscopy examination with excision of all polyps visualized and anatomopathological analysis, except for a short time of analysis in NBI for each polyp detected before excision to classify the polyp in existing endoscopic classifications (ie NICE classification for adenomatous polyps and WASP classification for festooned polyps).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2018
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 21, 2018
CompletedFirst Posted
Study publicly available on registry
February 28, 2018
CompletedStudy Start
First participant enrolled
July 9, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 12, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 12, 2022
CompletedResults Posted
Study results publicly available
November 29, 2024
CompletedNovember 29, 2024
October 1, 2024
4 years
February 21, 2018
July 10, 2024
October 16, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Sensitivity of the NBI Compared to the Anatomopathological Analysis (= Reference Method)
Number of polyps characterized as scalloped (NICE II-) by NBI relative to the number of polyps characterized as scalloped in standard histology
An average of 1 month
Study Arms (1)
Colonoscopy with NBI
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- Major patient with a colonoscopy scheduled in one of the participating hospitals (CHD Vendée and CHU Nantes).
- Patient who agreed to participate in the study and gave his express consent
- Patient affiliated with a social security system or beneficiary of a scheme
- Patient with 1 or more polyps less than 20 mm observed during colonoscopy
You may not qualify if:
- Patient with an emergency colonoscopy for ongoing digestive bleeding or occlusion symptoms
- Patient with chronic inflammatory bowel disease (IBD): Crohn's disease or unclassified colitis
- Patient with familial adenomatous polyposis
- Pregnant or lactating woman
- Minor patient
- Major patient under tutorship, curatorship, or deprived of liberty
- Patient unable to understand protocol and / or give express consent
- Patient not affiliated with a social security system or beneficiary of such a scheme
- Patient hospitalized or treated without their consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Centre Hospitalier Départemental Vendée
La Roche-sur-Yon, 85925, France
Centre Hospitalier Universitaire Nantes
Nantes, 44000, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Vincent MACE
- Organization
- Centre Hospitalier Départemental Vendée
Study Officials
- STUDY DIRECTOR
Vincent MACE
Centre Hospitalier Départemental Vendée
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 21, 2018
First Posted
February 28, 2018
Study Start
July 9, 2018
Primary Completion
July 12, 2022
Study Completion
July 12, 2022
Last Updated
November 29, 2024
Results First Posted
November 29, 2024
Record last verified: 2024-10